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The use of magnetic iron oxide nanoparticles in biomedicine has evolved intensely in the
recent years due to the multiple applications of these nanomaterials, mainly in domains
like cancer. The aim of the present study was: (i) to develop biocompatible colloidal
suspensions based on magnetic iron oxide nanoparticles as future theranostic tools for
skin pathology and (ii) to test their effects in vitro on human keratinocytes (HaCat cells) and
in vivo by employing an animal model of acute dermal toxicity. Biocompatible colloidal
suspensions were obtained by coating the magnetic iron oxide nanoparticles resulted
during the solution combustion synthesis with a double layer of oleic acid, as innovative
procedure in increasing bioavailability. The colloidal suspensions were characterized in
terms of dynamic light scattering (DLS) and transmission electron microscopy (TEM).
The in vitro effects of these suspensions were tested by means of Alamar blue assay
and the noxious effects at skin level were measured using non-invasive methods.
The in vitro results indicated a lack of toxicity on normal human cells induced by the
iron oxide nanoparticles colloidal suspensions after an exposure of 24 h to different
concentrations (5, 10, and 25 µg·mL−1). The dermal acute toxicity test showed that
the topical applications of the colloidal suspensions on female and male SKH-1 hairless
mice were not associated with significant changes in the quality of barrier skin function.
Keywords: bioavailability, skin barrier, toxicity, magnetic iron oxide nanoparticles, colloidal suspensions, solution
combustion synthesis
Abbreviations: AOA, antioxidant activity; CIE, Commission Internationale de L’Eclairage; DBET, particle diameter from
BET; DLS, dynamic light scattering; DMEM, Dulbecco’s modified Eagle Medium; DPPH, 1,1-Diphenyl-2-picryl-hydrazyl;
DXRD, crystallite size; FBS, Foetal Bovine Serum; HaCat cells, human keratinocytes cell line; Hc, coercivity; Mr, remanent
magnetization; MRI, magnetic resonance imaging; Ms, saturationmagnetization; OA, oleic acid; PBS, phosphate saline buffer;
SBET, specific surface area; TEM, transmission electron microscopy; i.v., intravenously administration.
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GRAPHICAL ABSTRACT
INTRODUCTION
The field of nanotechnology has known a considerable progress
in recent years, mainly regarding its involvement in different
biomedicine applications. There were recorded extensive efforts
to develop effective nanomaterials as diagnostic, prevention and
treatment tools for cancer and other disorders, such as infectious,
cardiovascular, and central nervous system diseases (Zdrojewicz
et al., 2015; Radomska et al., 2016; Torres-Sangiao et al., 2016).
The interest for the liaison between nanoparticles and medicine
could be quantified by the number of articles enlisted in the
PubMed database—over 130,000 at the moment that this article
was written (November 2016), number acquired after a search for
“nanoparticles.”
From the great number of nanoparticle types, magnetic
nanoparticles attracted an increased attention due to their
potential use in multiple medicine branches, such as: magnetic
resonance imaging, thermal therapy, cell labeling, drug, and gene
targeted delivery, in vitro diagnosis, immunoassays, nucleic acid
concentration (reviewed in Gobbo et al., 2015; Medeiros et al.,
2015). The group of magnetic nanoparticles includes: pure metals
(iron, nickel, and cobalt), metal alloys or metal oxides (Conde
et al., 2014; Soares et al., 2016). Iron oxide nanoparticles are the
highest ranked nanomaterials in medicine due to their unique
physico-chemical properties (superparamagnetism) and their
established biocompatibility and stability in aqueous solutions
(Medeiros et al., 2015; Soares et al., 2016, reviewed in Valdiglesias
et al., 2016). Iron oxide nanoparticles were employed for multiple
clinical applications, including: magnetic resonance imaging
(MRI) as contrast agents, drug carrier platforms for anticancer
agents, magnetic cell separation, in high-gradient magnetic field
separations, treatment of retinal detachment, bio-catalysis, and
protein purification (Shete et al., 2015; Tran et al., 2015).
Besides this, bioavailability of orally introduced Fe (III) oxide
nanoparticles (in form of hematite) was characterized in male
Wistar rats (Raspopov et al., 2011). Nanoparticles of ferric oxide
with mean size 13.4 nm were capable to restore iron deposits of
animals impaired as a result of iron-deficient diet consumption.
A plus of the iron oxide nanoparticles consists in the fact
that this type of nanoparticles are not charged or aggregated at
physiological pH due to their isoelectric point—7; aggregated
nanoparticles being easily detected by the immune cells and
cleared from the organism before they could fulfill their
assignment (Tran et al., 2015).
For biomedical uses are considered adequate only the
magnetic nanoparticles that comply with the following
requirements: superparamagnetic properties at room
temperature, a wide saturation magnetization, a size in the range
of 20 nm for in vivo administration and to be biocompatible
(Shete et al., 2015). In order to convert the pure magnetic
nanoparticles into biocompatible dispersions it was proposed
the use of different polymers as capping agents or surfactants,
like: starch, chitosan, dextran, oleic acid, polyethylene glycol, etc.
(Józefczak et al., 2012; Medeiros et al., 2015; Shete et al., 2015).
For the synthesis of iron magnetic nanoparticles was
proposed an array of methods, including: mechanical grinding,
arc discharge, high temperature decomposition of organic
precursors, chemical co-precipitation, laser ablation, gas
deposition, electron beam lithography, reverse micelles method,
hydrothermal method, microemulsion, solvothermal method,
solution combustion synthesis, etc. (reviewed in Gupta and
Gupta, 2005; Sun et al., 2007; Li et al., 2010; Ianos¸ et al., 2012;
Velusamy et al., 2016). Among all these methods, solution
combustion synthesis was proved to be a promising alternative
for the preparation of a considerable number of metal oxide
nanopowders with multiple benefits: short preparation time, low
energy consumption, cheap starting materials, self-sustained
reaction, high effectiveness, simple procedure and low cost
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apparatuses and suitability for mass production (Ianos¸ et al.,
2012; Huang et al., 2016).
In the present study, biocompatible colloidal suspensions of
magnetic iron oxide nanoparticles coated with oleic acid were
prepared and characterized. There were investigated the effects
of these nanoparticles both in vitro on normal cell lines —
human keratinocytes (HaCat cells) and in vivo by evaluating the
acute dermal toxicity after topical application of the colloidal
suspensions.
MATERIALS AND METHODS
Materials
Chemicals and Reagents
The reagents used for the synthesis of Fe3O4 (magnetite)
and γ-Fe2O3 (maghemite) nanoparticles and of the colloidal
suspensions were: Fe(NO3)3·9H2O (Roth)—as oxidizing agent,
C6H8O7·H2O (Silal Trading) and D-(+)-C6H12O6 (Riedel de
Haën)—as fuels and oleic acid—C18H34O2 (Merck 65–88%)—
as surfactant. The cell culture media—Dulbecco’s modified Eagle
Medium with high glucose and the other chemicals used for
cell culture: Fetal Bovine Serum (FBS), penicillin/streptomycin,
PBS (phosphate saline buffer), Trypsin/EDTA, Trypan Blue,
and Alamar blue solutions were bought from Sigma Aldrich,
Germany. The ethanol was purchased from Chimreactiv-
Bucharest, Romania. All chemicals were of the highest grade of
purity commercially available.
Cells
The cell line used in this study was of human origin: human
keratinocytes—HaCat cells (was offered by the University of
Debrecen, Hungary). The cell line was kept in standard
conditions before culture (liquid nitrogen).
Animals
The animals used for the acute dermal toxicity test were female
and male SKH-1 hairless mice purchased from Charles River
Laboratories (Budapest, Hungary) and kept in the university
animal facility.
Methods
Synthesis of Fe3O4 Nanoparticles
The magnetite and maghemite nanoparticles used for the
preparation of colloidal suspensions were synthesized using a
new version of the solution combustion synthesis (Ianos¸ et al.,
2012, 2014). The aqueous solution containing Fe(NO3)3·9H2O
and C6H8O7·H2O (fuel for the synthesis of magnetite), D-(+)-
C6H12O6 (fuel for the synthesis of maghemite) respectively,
was heated to 400◦C in the absence of air, in a round bottom
flask. As the water evaporated, a smoldering combustion reaction
occurred, leading to the formation of a black powder. The
resulted black powder was hand crushed, washed with warm
distilled water and dried at 80◦C (for samples S1 and S2). The
black powder resulted by using glucose as fuel was further treated
with H2O2 in order to remove the residual carbon present on the
surface of particles after combustion reaction (for sample S3).
Preparation of Stable Colloidal Suspensions
The protocol used for the preparation of the colloidal suspensions
by coating with a double layer of oleic acid, was a modified
version of the protocol described by Bica et al. (2007). In brief,
the iron oxide nanoparticles prepared by solution combustion
synthesis were sonicated for several hours and then covered
with a double layer of oleic acid. For the coating process it was
used an excess of oleic acid (2:1 ratio). The residual oleic acid
and the other salts were eliminated by decantation and it was
obtained a dispersion of oleic acid double layer coated iron oxide
nanoparticles, that was further dissolved in phosphate buffered
saline (PBS—sample S1) and in distilled water (samples S2 and
S3) respectively, leading to stable colloidal suspensions.
Characterization of the Iron Oxide Nanoparticles
Iron oxide nanoparticles were characterized in terms of
XRD phase composition (Rigaku Ultima IV, CuKα, Tokyo,
Japan), specific surface area (nitrogen adsorption-desorption,
Micromeritics ASAP 2020, Micromeritics Instrument
Corporation, Norcross, USA) and magnetic properties (VSM
880 ADE/DMS magnetometer DMS/ADE Technologies,
Massachusetts, USA).
Characterization of the Colloidal Suspensions
The resulted colloidal suspensions solubilized in PBS (sample S1)
and in distilled water (samples S2 and S3) were characterized
by dynamic light scattering—DLS, using a ZetaSizer NanoZS
Malvern Instrument (Worcestershire, UK). The morphology and
ultrastructure of aggregates and nanoparticles were characterized
by transmission electron microscopy (TEM) using a FEI Tecnai
12 Biotwin, (Oregon, SUA) electron microscope. The samples
obtained as described in the previous section were sonicated for
15 min. After the sonication, 1 drop from each sample was placed
on the copper grid surface. This method was used to determine
the size of the nanoparticles.
Antioxidant Activity of the Iron Oxide Colloidal
Suspensions
The antioxidant activity of the samples was evaluated by DPPH
radical scavenging assay which was originally described by Blois
(1985). The solution of DPPH (1 mmol·L−1) was used as a
standard reagent. As control, it was prepared a solution of
ascorbic acid (from Lach-Ner; 0.167 mmol·L−1) in ethanol 96%.
From each sample (S1, S2, S3) there were made three dilutions:
1:10; 1:50; 1:100, as presented in Table 1.
A mixture of: 0.5 mL of each dilution, 2 mL ethanol 96%
and 0.5 mL DPPH ethanolic solution was analyzed using a
T80UV/VIS Spectrophotometer (PG Instruments LtD) at 516 nm
for 20 min.
Antioxidant activity was calculated using the following
formula:
AOA (%) = 100−
At516
A(t= 0)516
· 100
Where: AOA= antioxidant activity
At516 = absorbance of the sample (S1, S2, S3) measured at
516 nm at a specific time
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TABLE 1 | Samples S1, S2, and S3 concentrations after dilution.
Sample Initial concentration,
Ci (mg·mL
−1)
Dilution Final concentration,
Cf (mg·mL
−1)
S1 10.4 1:10 1.04
1:50 0.208
1:100 0.104
S2 52 1:10 5.2
1:50 1.04
1:100 0.52
S3 78 1:10 7.8
1:50 1.56
1:100 0.78
A(t= 0)516 = absorbance of the blank solution measured at
516 nm (without test sample− S1, S2, S3).
Cell Culture
The human keratinocytes—HaCat were cultured in Dulbecco’s
modified Eagle Medium (DMEM) with high glucose (4.5 g·L−1),
15 mM Hepes, and 2 mM L-glutamine, supplemented with 100
U·mL−1 penicillin, 100 µg·mL−1 streptomycin, and 10% fetal
bovine serum (FBS). The cells were kept in standard conditions: a
humidified atmosphere with 5% CO2 at 37◦C and were passaged
every 2 days. Cell number was determined using the cell counting
chamber—Neubauer in the presence of Trypan blue.
Viability Assay—Alamar Blue
The viability was measured using the Alamar blue technique, a
classical assay to measure the cytotoxicity induced by different
agents. The cells (1 x 104/200 µL medium/well) were seeded in
a 96-well plate and allowed to attach. After the cells attached
to the plate, were stimulated with different concentrations (5,
10, and 25 µg·mL−1) of the 3 colloidal suspensions for 24 h.
Before the Alamar blue reagent be added, the medium that
contained the suspensions was removed and new medium was
added into each well—200 µL/well (the iron nanoparticles could
interfere with the spectrophometrical measurement of Alamar
blue and the results might have been false positive). At 24 h
post-stimulation, it was added a volume of 20 µL/well of Alamar
blue solution (10% of the volume of cell culture medium present
in each well—200 µL). The plates were incubated for 3 h at
37◦C, followed by the measurement of the absorbance using
xMarkTMMicroplate Spectrophotometer (Biorad). Cell viability
was calculated according to the formula used in one of our
previous articles (S¸oica et al., 2014).
Scratch Assay
This assay represents an in vitro wound healing assay and
was used to determine how fast a generated gap in the
monolayer can be repopulated by migrating cells, and to
define differences in migration or proliferation under various
experimental conditions.
The scratch assay protocol was applied according to the data
from the literature (Jung et al., 2012): 2 × 105 cells/well were
seeded in 12-well culture plates 1 day prior to the experiment.
Scratches were performed in a defined area using a small pipette
tip (10 µL). Detached cells and medium were removed by
washing with PBS prior to treatment. Cells were observed over a
period of 24 h. Photos of the scratches were taken at different time
points (0, 3, and 24 h) using an Optika Microscopes Optikam Pro
Cool 5 and Optika View.
In vivo Acute Dermal Toxicity
The experimental procedures and protocols that were applied
in the present study were in agreement with the European
Directive 2010/63/EU and the National Law 43/2014 regarding
the protection of animals used for scientific purposes. The
experimental protocol was approved by the Committee for
Research Ethics of “Victor Babes¸” University of Medicine and
Pharmacy, Timis¸oara, Romania. The animals received food and
water ad libitum and were kept in the University animal facility
under standard conditions [constant temperature of 22.5 ± 2◦C
and relative humidity of 55% ± 5%, 12 h (light)—12 h (dark)
cycle]. The animals used in the study were adult female and male
SKH-1 hairless mice (n = 5/group). The acute dermal toxicity
was tested according to the OECD guideline 402. The female
mice were non-pregnant. Before the experiment, the mice were
acclimatized to the laboratory conditions for 2 weeks and were
divided in 3 groups/sex: group 1—mice that received topically the
colloidal suspension of magnetite—S1 (in PBS), group 2—mice
that received topically the colloidal suspension of magnetite—S2
(in distilled water) and group 3—mice that received topically the
colloidal suspension of maghemite—S3 (in distilled water). The
volume of colloidal suspension topically administered was 100
µL/3 times at an interval of 20 min between applications. These
volumes were applied on the first day of experiment and the
animals were monitored for a period of 14 days. The parameters
evaluated were: changes in mice weights, behavioral pattern
(salivation, tremors, lethargy, sleep, and coma) and changes in
skin appearance by measuring the physiological skin parameters
values.
Non-invasive Skin Parameters Measurements
The skin parameters were measured by the means of a
non-invasive technique using the equipment from Courage-
Khazaka, Germany: an electronic Skin Colorimeter CL 400
and the Corneometer R©CM 825. The Skin Colorimeter CL 400
principle is based on the tristimulus colorimetry and uses the
Commission Internationale de l’Eclairage (CIE) L∗a∗b∗ color
system to determine skin color modifications. The color was
expressed using the parameters L∗a∗b∗, where: L∗ measured skin
reflectance or lightness (a gray scale with values ranging from 0
to 100 where 0 is black and 100 is white); a∗ measures the colour
saturation from red to green (scale from +60 to −60, where
positive values indicate varying intensities of red); b∗ measures
the color saturation from yellow to blue (scale+60 to−60, where
positive values indicate varying intensities of yellow; Alaluf et al.,
2002). The L∗a∗b∗ parameters were expressed as arbitrary units.
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TABLE 2 | Characteristics of the colloidal suspensions based on iron oxide nanoparticles.
Powder
no.
The combustible
used in combustion
reaction
The phase
composition
obtained
The density of the
colloidal suspension
(g/cm3)
The density of the
dispersion medium
(g/cm3)
The mass of iron
oxide calculated / ml
suspension (g)
S1 C6H8O7·H2O
Citric acid
Fe3O4 1.0126 PBS—1.0044 0.0104
S2 C6H8O7·H2O
Citric acid
Fe3O4 0.9956 Water—0.9465 0.0520
S3 C6H12O6
Glucose
γ-Fe2O3 1.0097 Water—0.9465 0.078
The hydration of the stratum corneum was determined using the
Corneometer R©CM 825 probe.
Statistical Analysis
The statistical programs and softwares applied in the present
study were GraphPad Prism 5 and Origin 8 (OriginLab—Data
analysis and Graphing Software).
RESULTS
Characterization of the Colloidal
Suspensions Based on Iron Oxide
Nanoparticles
The colloidal suspensions (magnetite—samples S1 and S2 and
maghemite—sample S3) doubled coated with oleic acid were
prepared using the iron oxide nanoparticles obtained during
the solution combustion synthesis. The coating process occurred
after the solution combustion synthesis using oleic acid in excess
as compared to the amount of nanopowder (2:1 ratio).
The main characteristics of the samples used in the present
study were presented in Table 2.
The density of the colloidal suspension and the density of
dispersion medium (distilled water or PBS) were measured using
a Portable Density Meter: DMA 35 from Anton Parr at 25◦C.
The volume fraction was calculated with the following formula:
ϕ =
ρCS − ρDM
5.2− ρDM
Where: ρCS- the density of coloidal suspension
ρDM - the density of dispersion medium
5.2- the density of F e3O4
The mass of iron oxide was calculated by multiplication of the
volume fraction of each colloidal suspension with 5.2 and with 1
mL of each colloidal suspension used.
In order to assess the particles size and distribution it was
applied the dynamic laser scattering (DLS) method. The results
recorded for the samples S2 and S3 (Figure 1) in terms of
intensity distribution of particles size revealed that the colloidal
suspensions were composed virtually of a single family of
particles with an average hydrodynamic diameter of 43 nm (S2—
green line) and 80 nm (S3—blue line), respectively. On the other
FIGURE 1 | The intensity distribution of particles size (DLS) of colloidal
suspensions.
hand, the sample S1 (red line Figure 1), presented a bimodal
particle size distribution, which suggests the presence of two
populations of particles with an average hydrodynamic diameter
of 63 nm.
The data concerning the morphology and the ultrastructure
of the colloidal suspensions were provided by the Transmission
Electron Microscopy (TEM) analysis. The size and shape of
nanoparticles were analyzed both in rather low magnification
(16,500x) and in higher magnification (220Kx). The
analysis of sample S2 in rather low magnification indicated
uniformly distributed aggregates (Figure 2), whereas in higher
magnification (220Kx) the nanoparticles were monodispersed
with polygonal shapes and an average size between 7 and 22 nm
(Figure 3).
TEM data recorded for sample 1 (magnetite double coated
with oleic acid solubilized in PBS) in high magnetization
showed a different shape of the nanoparticles and a larger size
as compared to the ones measured in sample 2 (magnetite
double coated with oleic acid solubilized in distilled water; see
Figure 3). In terms of homogenous size and distribution of
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FIGURE 2 | TEM micrograph of the sample S2, general aspect of
aggregates in rather low magnification (16,500x).
the nanoparticles, all three samples analyzed presented these
characteristics (Figure 3).
According to the measurements (in high magnification) in
all three samples (S1, S2, and S3), it could be observed an
inverse correlation between the iron oxide concentration in the
sample and the nanoparticle size. In the samples with a higher
concentration of iron oxide it was observed a decreased value
of nanoparticle size (7.64 nm–sample S2 and 13.52 nm–sample
S3), whereas in the sample with a lower concentration in Fe3O4
(sample S1), the nanoparticles had an increased size (21.46 nm;
see Figure 4).
Antioxidant Activity of the Iron Oxides
Colloidal Suspensions
The antioxidant activity of the samples was evaluated by DPPH
radical scavenging assay. There were prepared three dilutions for
each sample (see Table 1) and tested for antioxidant activity.
In Figure 5 was presented the antioxidant activity (AOA) of
all three samples of biocompatible magnetic colloidal suspension
based on iron oxide nanoparticles. The antioxidant activity
assessment was carried out for 1,200 s, but we chose to represent
only the data recorded until 400 s during this time being detected
most of the activity (after this time point no significant activity
was detected until the end of experiment).
According to our results, all the samples showed a
reduced antioxidant activity as compared to the AOA of
ascorbic acid, used as positive control. Furthermore, sample
S1 (magnetite—Fe3O4 nanoparticles dispersed in PBS) did not
exhibit antioxidant activity for any dilution analyzed. In the
case of sample S3 (maghemite—γ-Fe2O3 nanoparticles dispersed
in water), the first dilution analyzed (1:10) did not reveal an
antioxidant activity, but at higher dilution the AOA of the sample
achieved a value of ∼20%. This could be explained by the fact
that this sample had the highest concentration in γ-Fe2O3 and a
dilution of 1:10 could be too concentrated to present antioxidant
activity.
FIGURE 3 | TEM micrograph of the samples. High magnification (220Kx).
The details of measurements of nanoparticles size are given in red.
The sample S2 (Fe3O4 nanoparticles dispersed in distilled
water)—contained the same type of nanoparticles (Fe3O4) as
sample S1, but the differences between S1 and S2 were the
amount of Fe3O4 (S1—10.4mg vs. S2—52 mg) and the liquid
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carrier (PBS/distilled water); this was the only sample that
showed antioxidant activity for each dilution. The fact that
the sample (S2) showed antioxidant activity compared with
FIGURE 4 | The inverse correlation between the iron oxide
concentration in samples and nanoparticle dimensions.
FIGURE 5 | AOA of all three samples of iron oxide colloidal
suspensions, including the dilutions.
the sample S1 could be explained by the liquid carrier—any
compound dispersed in water shows a higher antioxidant activity
compared to the same compound dispersed in other liquid
carrier, and by the amount of Fe3O4 in the sample.
In Figure 6 was presented the AOA of the samples both at
initial and at the final moment. As it could be seen, the AOA
(for each dilution) increased in time, this increase being in an
inversely proportional relation with the samples concentration.
This could be explained by the fact that a colloidal suspension
based on iron oxides shows antioxidant activity only when the
concentration in Fe3O4 or γ-Fe2O3 was higher and the solid
fraction was dispersed in distilled water.
Evaluation of Magnetic Colloidal
Suspensions Effects on Cell Viability
Cells viability was expressed as percentage of viable cells (%)
related to the control cells (the cells that were stimulated with
the same concentration of solvent—for sample—S1—PBS and for
samples—S2 and S3—distilled sterile water). This parameter was
assessed by the means of Alamar blue technique.
Stimulation of the HaCat cells with different concentrations
(5, 10, and 25 µg·mL−1) of samples S1, S2, and S3 colloidal
suspensions for 24 h led to an increase of cell viability
as compared to control cells, what indicated that the iron
nanoparticles did not affect cells viability (Table 3). Similar
results were obtained for a higher concentration (50 µg·mL−1)
in the case of all three test samples—S1, S2, and S3 (data not
shown).
TABLE 3 | In vitro effect of samples S1, S2, and S3 after 24 h stimulation.
Samples Percentage of viable HaCat cells (%)
PBS/H2O 5 µg·mL
−1 10 µg·mL−1 25 µg·mL−1
S1 100 111.47 101.49 109.26
S2 100 118.45 129.15 102.78
S3 100 131.38 128.11 119.67
FIGURE 6 | The AOA of the samples at initial (t = 0 s) and at the final (t = 1,200 s) moment.
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FIGURE 7 | The effect of S1 colloidal suspension on HaCat cells migration and proliferation. The cells were stimulated with different concentrations of the
colloidal suspension (C1 = 5, C2 = 10, and C3 = 25 µg·mL−1 ) and were taken photos at 0, 3, and 24 h post-stimulation.
FIGURE 8 | The effect of S2 colloidal suspension on HaCat cells migration and proliferation. The cells were stimulated with different concentrations of the
colloidal suspension (C1 = 5, C2 = 10, and C3 = 25 µg·mL−1 ) and were taken photos at 0, 3, and 24 h post-stimulation.
Effects of Magnetic Colloidal Suspensions
on Cell Migration and Proliferation
The effect of the magnetic iron oxide nanoparticles colloidal
suspensions on cell migration and proliferation was assessed by
the means of scratch assay, a wound healing type technique. After
the scratches were drawn (when the confluence of the cells was
around 90%), the cells were stimulated for 24 h with the same
concentrations tested for the cytotoxic effect. There were taken
pictures at different time points (0, 3, and 24 h) in order to
pursue the impact of the test suspensions on cells migration and
proliferation.
As it can be seen in Figure 7, the S1 colloidal suspension did
not affect the normal keratinocytes—HaCat migration, neither
after 3 h, nor after 24 h, moreover, could it be said that the test
suspension had a stimulatory effect on cells proliferation. The
cells were abundant on the plate and well attached.
The Figures 8, 9 showed that the samples S2 and S3 colloidal
suspensions induced a similar effect onHaCat cells migration and
proliferation as the one described for sample S1: a stimulatory
effect, results that were in agreement with the data recorded for
the cytotoxicity test.
In vivo Evaluation of Acute Dermal Toxicity
The in vivo effects of the colloidal suspensions of magnetite and
maghemite coated with a double layer of oleic acid were tested
employing the OECD guideline 402 protocol for acute dermal
Frontiers in Pharmacology | www.frontiersin.org 8 March 2017 | Volume 8 | Article 154
Coricovac et al. Iron Oxide Nanoparticles: Toxicological Profile
FIGURE 9 | The effect of S3 colloidal suspension on HaCat cells migration and proliferation. The cells were stimulated with different concentrations of the
colloidal suspension (C1 = 5, C2 = 10, and C3 = 25 µg·mL−1 ) and were taken photos at 0, 3, and 24 h post-stimulation.
toxicity. The mice used in the study were female and male SKH-
1 hairless mice. The body weights of the mice were recorded
every 2 days for 14 days and no significant modifications were
observed neither in the female groups, nor in male groups.
Concerning the behavioral patterns (salivation, lethargy, sleep,
and coma), there were observed no such signs in any groups
of mice during the experiment frametime. These data indicated
that topical applications of iron colloidal suspensions were not
associated with weight loss or interferences at nervous system
level.
Another parameter that was assessed was the skin appearance
after topical application of the iron colloidal suspensions. The
changes in skin appearance were characterized by monitoring
the evolution of skin physiological parameters—skin hydration,
melanin content and erythema using a non-invasive technique.
The measurements were performed before the application of the
colloidal suspensions (values considered as controls), after each
application (at 20, 40, and 60 min), at 6 h, 24 h and in every
second day until the last day of experiment (day 14). The most
significant changes were observed in the first 24 h. Until the end
of experiment the values were constant (data not shown).
Topical application of the iron colloidal suspensions led to
some changes in the values of skin hydration both in the female
and male groups of mice (Figure 10). S1 colloidal suspension
in PBS (red line) led to a decrease in the skin hydration value
in the females group with each application (in the first 1 h),
but the measurements at 6 h and 24 h indicated a similar value
to the one measured before the application of the colloidal
suspension (control value) and this value continued in the same
range until the end of experiment. In the case of S2 and S3
iron colloidal suspensions in distilled water (blue and yellow
lines) it was detected an increase of the parameter in the
first hour, this hydration status being maintained in the first
24 h.
Group 1 of male mice (S1 treated—red line) indicated an
increase of skin hydration value in the first hour (after the 3
successive applications), but after 6 h the value of the parameter
returned at the initial value (before topical application) and
continued in this range until the end of experiment. When were
applied S2 and S3 iron colloidal suspensions the evolution of skin
hydration in the groups of male mice was similar with the one
observed in the female groups—an increase value in the first hour
and this value was maintained in the first 24 h.
Melanin content and the erythema were measured by the
means of tristimulus colorimetry using the skin colorimeter CL
400 probe (Courage–Khazaka, Germany).
The iron colloidal suspensions were applied in the posterior
thorax region of the mice (females and males) and the tristimulus
colorimetric L∗a∗b∗ measurements were recorded before each
application (in the first hour), at 6 h, 24 h, and every 2 days
until the end of the experiment. There were analyzed the values
for L∗–skin reflectance (lightness) and b∗–yellowness, associated
with melanin content, and a∗–redness, an indicator for erythema.
For the females from group 1 that received S1 colloidal
suspension in PBS (red line—Figure 11, left graph) there were
observed the following aspects: 1L∗ value decreased after the
first application of the S1 suspension (at 20 min), the second
application led to an increase of this parameter (at 40 min) and
the third application was accompanied by a decrease of1L∗ value
(at 60 min) as compared to the one recorded after the second
application. At 6 h after the first application the 1L∗ value was
similar with the one recorded after the second application (at 40
min), whereas at 24 h the value was in the same range with the
one recorded after the third application (at 60 min).
In the case of 1b∗ for the females from group 1 (S1
colloidal suspension topically applied—red line, Figure 11, right
graph) the evolution of this parameter was as follows: the
first application (at 20 min) led to an increased value as
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FIGURE 10 | Skin hydration evolution during the first 24 h of experiment. Data are expressed as mean of the values measured at every time point (three
successive measurements of the parameter/mouse).
FIGURE 11 | Melanin-related measurements for SKH-1 females. The values were expressed as 1L* and 1b*, 1—is the difference between the mean value of
the test group obtained for L* and b*, respectively (for each time point) and the mean values for these coordinates in the control group (the values measured before
the application of the suspensions).
compared to the control (non—treated), a decrease after the
second application (at 40 min) and the third application (60
min), an increase at 6 h and a reduced value at 24 h. The L∗
(lightness or brightness) and b∗–yellowness were described to
be inversely correlated, an increase of L∗ value was associated
with the decrease of b∗ value (and reverse) and the presence
of pigmentation/augmentation of melanin content in the skin.
Based on this correlation, our results indicated a pigmentation
after the first application of S1 colloidal solution (low 1L∗ and
high1b∗), after the second and third applications (high1L∗ and
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FIGURE 12 | Melanin-related measurements for SKH-1 males. The values were expressed as 1L* and 1b*, 1—is the difference between the mean value of the
test group obtained for L* and b*, respectively (for each time point) and the mean values for these coordinates in the control group (the values measured before the
application of the suspensions).
low 1b∗) the skin recovered and no pigmentation was recorded
until the end of experiment.
Group 2 of female mice topically exposed to S2 colloidal
solution—in distilled water presented some variations in the
1L∗ values during the experiment, especially in the first 24 h
(blue line, Figure 11, left graph): a decrease after the first (at
20 min) and second (at 40 min) applications (more significant
after the first application), an increase after the third application
(at 60 min) followed by a reduced value at 6 and 24 h. An
inversely evolution was recorded for 1b∗ (blue line, Figure 11,
right graph) values in the same group: an increase of the value
after the first application (at 20 min), a decrease after the second
(at 40 min) and third (at 60 min) applications, followed by
increased values at 6 and 24 h. These data showed that application
of S2 colloidal suspension induced a significant pigmentation/ an
augmentation of melanin content after the first application, the
skin tried to recover after the third application (high L∗ and low
b∗), but the pigmentation became more intense after 6 and 24 h,
respectively.
The results recorded for group 3 of female mice topically
exposed to S3 colloidal suspension (maghemite) in distilled water
concerning 1L∗ parameter (yellow line, Figure 11, left graph)
showed: a decrease after the first application (at 20min), followed
by an increase after the second and the third applications,
increase that continued in the same range at 6 and 24 h, too.
In the case of 1b∗ values, for group 3 of females mice were
recorded only positive values, these values presenting a linear
correlation with1L∗ values (yellow line, Figure 11, right graph),
data that were in contrast with the ones measured for the other
two suspensions, S1 and S2, an explanation being the fact that
S3 suspensions did not induce any changes in the melanin
content.
In order to quantify the effect induced by the S1, S2 and
S3 colloidal suspensions on melanin content in the male mice
groups, the parameters L∗ and b∗ were measured. In the first
group ofmalemice (topically treated with S1 colloidal suspension
in PBS) was determined the following evolution for 1L∗ values
(red line, Figure 12, left graph): all the three applications induced
a decrease of 1L∗ (similar negative values), at 4 h after the
first application the value of 1L∗ became positive reaching a
maximum at 6 h and continued in the same range until 24 h.
The values recorded for1b∗ (red line, Figure 12, right graph) in
the same group of mice were in an inverse relationship with1L∗
after the three applications of the S1 colloidal suspension (low L∗
and high b∗), while the values recorded at 6 and 24 h presented
an ascending trend. These results could be explained as the
development of a temporary pigmentation under the incidence
of the applied suspensions followed by a recession of this status
after 6 h post-application.
1L∗ values measured in group 2 of male mice—exposed to
S2 colloidal suspension in distilled water (blue line, Figure 12,
left graph) exhibited the following tendency: a decrease after
the 3 successive applications (negative values, the highest being
recorded after the second application). The values at 6 and 24
h were closed to the ones calculated after the first and third
applications. The other parameter evaluated 1b∗ presented an
evolution inversely correlated with the 1L∗ values (low L∗
and high b∗ and reverse; blue line, figure 12, right graph).
These results showed that S2 suspension topically applied led
to an elevation of melanin content in the skin of male mice,
pigmentation that was conserved during the 24 h.
The results obtained in the case of group 3 of male mice
exposed to S3 colloidal suspension in distilled water (maghemite;
yellow line, Figure 12, left and right graphs) were similar with
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FIGURE 13 | Erythema-related measurements. The values were expressed as 1a*, where 1—is the difference between the mean value of the test group
obtained for a* (for each time point) and the mean value for this coordinate in the control group (the values measured before the application of the suspensions).
the ones obtained for group 3 of female mice showing a directly
correlation between 1L∗ and 1b∗, data that could be explained
as no impact of this suspension—S3 on melanin content.
Another skin parameter measured in order to characterize
the changes in the skin color post-application of the test
suspensions was 1a∗—redness or the green-red chromaticity
coordinate related to erythema occurrence.1a∗ and1L∗ are also
interrelated in a linear inversely relationship, the lower the L∗
value is, the higher the a∗ value should be and also the degree
of redness and erythema.
For group 1 of female mice (exposed to S1 suspension) the
values of 1a∗ that respected the inverse correlation with 1L∗
were only the values recorded after the second and the third
applications (at 40 and 60 min), the others being in a direct
correlation. The data could indicate that the erythema occurred
starting with the second application and in time after 6 and 24
h the reaction faded and was retracted (red line, Figure 13, left
graph).
The values calculated for the second group of female mice
(exposed to S2 suspension) presented a similar tendency as the
one observed to group 1, but the first signs of erythema were
detected after the first application and the skin recovered after
6 h (blue line, Figure 13, left graph).
In group 3 of female mice (exposed to S3 suspension), the
relationship between1a∗ and1L∗ was a linear directly one, what
could be associated with a lack of effect on this parameter (yellow
line, Figure 13, left graph).
There were also observed some variations of the values
calculated for 1a∗ in the groups of male mice as compared to
control values that were measured before the application of the
suspensions.
The first group of mice (exposed to S1 suspension) presented
a direct correlation between 1a∗ and 1L∗ (high a∗ and high L∗)
what could be explained as the absence of an impact on erythema
values (red line, Figure 13, right graph). In the second group of
male mice (exposed to S2 suspension), there were detected some
signs of erythema after the first and the third applications (high
a∗ and low L∗), but the erythema attenuated in time (at 6 h; blue
line, Figure 13, right graph).
The male mice from group 3 (exposed to S3 suspension)
presented signs of erythema starting with the first application
and the signs were still visible after 24 h. These data could be
explained by the inverse correlation between1a∗ and1L∗ values
calculated in this group (yellow line, Figure 13, right graph).
DISCUSSIONS
Iron oxide nanoparticles were found in different polymorphic
phases, as: α, β, γ, δ, and ε—Fe2O3, maghemite (γ—Fe2O3) and
magnetite (Fe3O4) being the two compounds mostly employed
in biomedical applications. Magnetite and maghemite represent
the first choice as magnetic nanoparticles for biomedical uses due
to their unique features, such as: superparamagnetic properties
per se–exhibit magnetism only in the presence of an external
magnetic field, a single magnetic domain with a large constant
magnetic moment and low toxicity (Muthukumaran and Philip,
2016; Velusamy et al., 2016). Magnetite was described to exceed
the maghemite from the point of view of magnetic susceptibility
and saturationmagnetization (Muthukumaran and Philip, 2016).
Magnetite (Fe3O4) presents a cubic crystal structure of inverse
spinel that has the Fe2+ cations located in the octahedral
site (site B—surrounded by 6 oxygen anions) and the Fe3+
cations distributed evenly between the tetrahedral (site A—
surrounded by 4 oxygen anions) and the B site (Li et al., 2010).
This distribution of the cations is responsible for the total
magnetization of the molecule (Marinca et al., 2016). Besides
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the metallic nanoparticles used as valuable tools to enhance
the effectiveness of the current therapies and to increase the
compliance of the patient to the treatments, there were described
other types of nanoparticles engineered in this direction, such
as: polymeric colloids, liposomes, solid lipid nanoparticles,
cyclodextrins, and others (Kuskov et al., 2010; Medeiros et al.,
2015; Soica et al., 2016).
The method used to synthesize iron oxide nanoparticles
is considered a key factor for the future applications of the
nanoparticles since the electrical, optical andmagnetic features of
these items are correlated to their size, parameter that is assigned
during this process (Li et al., 2010). Other parameters that should
be strictly controlled in the synthesis of iron oxide nanoparticles
are shape, uniformity, crystallinity, and crystal structure (Jiang
et al., 2014).
There were described some inconveniences concerning the
methods used for the synthesis of iron oxide nanoparticles (poor
monodispersity, irregular shape of the particles; Bloemen et al.,
2012). Finding the proper method to obtain magnetic iron
oxide nanoparticles with a reduced number of inconveniences
related to the physico-chemical properties of the nanoparticles, in
terms of stability, biocompatibility, the proper size and shape for
biomedical uses, represented a real challenge for the researchers.
A method that complies with most of these requirements
was proved to be the solution combustion method. Solution
combustion synthesis was described as a simple, universal and
low time consuming method that could be applied for the
preparation of a variety of nanosize materials. This type of
procedure it’s based on a self-sustained reaction that requires
the presence of oxidants (homogenous solutions) and fuels
(like: urea, glycine, hydrazides, etc.). The resultant products of
this procedure are nanosize oxide materials, but this method
also delivers a homogeneous concentration of trace amounts of
rare-earth impurity ions in a single step. Solution combustion
synthesis proved to be an efficient method for the procurement of
different metal nanopowders, such as: Ni, Zn, Cd, Al, Ti, Cu, Fe,
etc. (reviewed in Aruna and Mukasyan, 2008; Ianos¸ et al., 2012,
2014; Huang et al., 2016).
In the present study, it was applied the solution combustion
synthesis in order to obtain the magnetic iron oxide
nanoparticles. The major advantage of the combustion method
is that the final reaction product is obtained directly after
combustion, without subsequent calcinations, therefore
the energy consumption is reduced. Phase composition,
morphology, and reactivity of the synthesized powders are
established based on the application of specific requirements
and controlled by synthesis conditions. In a study developed
by Gupta and Wells it was shown the selective behavior of
the magnetic iron oxide nanoparticles obtained by the means
of combustion synthesis (toxic for tumor, but protective with
normal cells), these results offering a new perspective on the
potential use of these magnetic nanoparticles in cancer therapy
(Gupta and Wells, 2004).
Ianos and co-workers proposed an adapted protocol for the
solution combustion synthesis in order to obtain nano-scaled
iron oxide nanoparticles (magnetite and maghemite; Ianos¸ et al.,
2012, 2014). For the synthesis of the iron oxide nanoparticles
analyzed in this study it was applied the protocol described by
Ianos et al. By employing the same method, the results that were
obtained in terms of physico-chemical properties are similar with
the ones showed by Ianos¸ et al. (2012; 2014), as follows: for
magnetite (DXRD—crystallite size = 18; SBET—specific surface
area = 56; DBET—particle diameter from BET = 21; Ms—
saturation magnetization = 57.7; Mr—remanent magnetization
= 4.5; Hc—coercivity = 5.2) and for maghemite (DXRD—
crystallite size = 5; SBET—specific surface area = 149; DBET—
particle diameter from BET = 8; Ms—saturation magnetization
= 41.5; Mr—remanent magnetization = 0.7; Hc—coercivity =
1). Considering the magnetic properties of the resulted powders,
it was observed that the saturation magnetization of the samples
S1, S2 prepared by combustion synthesis was slightly higher
than that of the sample S3 which after combustion was washed
with oxygenated water in order to remove the carbon from the
magnetic nanoparticles surface. At the same time, the remanent
magnetization and the coercivity of combustion synthesized
magnetic nanoparticles were very close to the superparamagnetic
behavior. The specific surface area of sample S3 was the highest,
which mean that the particles are very small, fact that was also
observed from the BET diameter. This aspect indicated that these
particles, obtained by combustion method, having narrow size
distribution with a size range of <50 nm, can be successfully
used for intravenous administration (i.v.), not only as magnetic
resonance imaging (MRI) contrast agents, vectors for gene and
drug delivery, or as agents for hyperthermia therapy (Boyer et al.,
2010; Estelrich et al., 2015).
One of the problems encountered in the synthesis of iron
oxide nanoparticles is the aggregation process characteristic for
the nanoscale particles with a large surface-to-volume ratio. The
solution proposed for this matter was the use of stabilizing agents
or coating agents that adhere to the surface of the nanoparticles
and offer a spatial isolation leading to the achievement of
monodisperse nanoparticles (Li et al., 2010). To avoid such
agglomeration and coagulation of the nanoparticles, they are
coated with specific surfactants that present in their structure
a hydrophobic element and a polar group. The hydrophobic
element is adsorbed on the surface of the nanoparticles whereas
the polar group enwidens into the water solution and protects
the nanoparticle against agglomeration, process that is known as
functionalization of the nanoparticle (Medeiros et al., 2015).
To obtain biocompatible colloidal suspensions of iron oxide
nanoparticles, in this study it was proposed as coating agent a
fatty acid—the oleic acid. Oleic acid (OA) is frequently used
as a capping agent for the iron oxides nanoparticles, because
it can form a dense protective monolayer, which is strongly
bonded to the surface of nanoparticles, thus being produced
monodisperse and uniform nanoparticles. If the iron oxide
nanoparticles are monolayer—coated with OA, these will be
dispersible only in organic solvents thereby limiting their use
for biomedical applications (Patil et al., 2014). A single layer
of OA is adequate for loading different hydrophobic drugs,
but is not biocompatible and appropriate for medical use due
to the presence of hydrophobic surfaces with a large surface
area that might lead to considerable particles size (aggregation
and big clusters formation) and recognition by the immune
Frontiers in Pharmacology | www.frontiersin.org 13 March 2017 | Volume 8 | Article 154
Coricovac et al. Iron Oxide Nanoparticles: Toxicological Profile
cells and clearance. In order to obtain biocompatible iron oxide
nanoparticle suspensions is required the addition of a hydrophilic
surfmer to the oleic acid monolayer used for functionalization of
the nanoparticles (Tran et al., 2015).
The novelty of the method that was proposed to prepare
biocompatible colloidal suspensions of iron oxide nanoparticles
in the present study consisted in coating with double layer of
OA the iron oxide nanoparticles resulted during the solution
combustion synthesis, method that was not described in the
literature, not to our knowledge. The coating process was
conducted in compliance with the protocol described by
Bica et al. (2007) with several modifications and there were
obtained OA double coated iron oxide nanoparticles that were
characterized in terms of DLS and TEM analyses.
The values that were measured for the particles size
dimensions of the three samples analyzed (S1—63 nm, S2—43
nm, S3—80 nm—Figure 1) by the means of DLS indicate that
the coated nanoparticles have a very narrow size distribution
range with superparamagnetic behavior at room temperature.
The hydrodynamic diameter of the coated nanoparticles is higher
as compared to the values measured for the pure/uncoated
nanoparticles, and this could be a confirmation of the
coating process. Furthermore, the nanoparticles are stable in
PBS/distilled water at neutral pH. Based on these data, it could be
said that the colloidal suspensions of the OA double coated iron
oxide nanoparticles obtained are suitable for in vitro and in vivo
applications, their dimensions being in the range established for
biomedical domain, an average particle’s diameter smaller than
100 nm and the polydispersity 0.1 (Shete et al., 2015; Medeiros
et al., 2015).
According to the TEM measurements and micrographs
(Figure 3) concerning the morphology and ultrastructure of the
colloidal suspensions, the results confirmed that the prepared
iron oxide particles were of nanosize, similar results being
described by Buzea et al. (2007). The values recorded for the
size of the nanoparticles from all the samples (see Figure 4)
are in the range of 7–22 nm, what could indicate the presence
of high polydispersity, results that are in accordance with the
data obtained from DLS measurements. It is known that DLS
measures the size of the aggregates not of a single iron oxide
particle and this could be an explanation for the differences
between the values of average particle diameter measured by
DLS technique and the ones recorded by TEM. Our results are
in agreement with the data from the literature (Li et al., 2010;
Medeiros et al., 2015; Shete et al., 2015).
A considerable number of studies used oleic acid inmonolayer
as coating agent for different nanoparticles engineered for
targeted drug delivery and release and the results showed that
this fatty acid played a crucial role in controlling the shape,
monodispersity and thermal stability of the nanoparticles (Li
et al., 2010; Tran et al., 2015; Muthukumaran and Philip, 2016;
Velusamy et al., 2016). Jiang et al. proved that the shape and
size of the magnetic iron nanoparticles synthetized by high-
temperature decomposition was influenced by the concentration
of oleic acid used as coating agent: the higher the concentration
of OA, the wider the particle size and of irregular shapes (Jiang
et al., 2014). Similar results regarding the impact of oleic acid
on particle size and shape dependent on concentration of acid
used, were described by Soares et al. in a study published in
2015 (Soares et al., 2015). The group of Marinca proposed a
novel method for the synthesis of magnetite nanoparticle coated
with oleic acid for biomedical purposes, which proved to be a
combination between the ceramic method and wet mechanical
milling and the results obtained highlighted the dual role of
oleic acid as surfactant and to prevent the coalescence of the
nanoparticles. Moreover, OA coating limits the contamination of
the resulted powder with iron and forbids the reaction between
magnetite and iron (Marinca et al., 2016).
The bond between the first layer of oleic acid and the
iron oxide nanoparticles could be explained by the interaction
between the carboxyl group from the oleic acid structure and
the surface of the iron oxide, probably through a coordination
of the iron atoms and both oxygen from the carboxyl group. The
hydrocarbon tail of the oleic acid remains free to interact with
the second surfactant—the surfmer (the active surfactant) and
leads to a solubilization of the coated iron oxide nanoparticles
in organic solvents (Medeiros et al., 2015; Shete et al., 2015). By
adding another layer of oleic acid to the iron oxide nanoparticles
coated with a first layer of oleic acid, it was achieved an aqueous
suspension of iron oxide nanoparticles with a long stability (more
than 3 months; Lan et al., 2007; Li et al., 2010).
The group of Ingram obtained magnetite nanoparticles by co-
precipitation method, that were further coated with a double
layer of oleic acid what provided them colloidal stability in water
at pH = 7–10 and proved to be efficient to stabilize the oil-water
emulsions with applicability in magnetic imaging and sensing
applications (Ingram et al., 2010). Our results are in concordance
with the data existent in the literature, since we obtained stable
water dispersible suspensions of OA double coated iron oxide
nanoparticles.
Concerning the antioxidant activity assessment, it was
observed that for an amount of 52mg of Fe3O4 (sample S2)
the AOA obtained was 20% for the dilution 1:100. This value
is similar to the one obtained in the case of using 72mg γ-
Fe2O3. Paul et al. investigated the antioxidant properties of iron
oxide particles of different sizes and showed that the free radical
scavenging efficiency of bare iron oxide nanoparticles (α-Fe2O3)
was found to be almost 50% for DPPH by 200mg of iron oxide
nanoparticles (Paul et al., 2009). Bhattacharya et al. found a very
high free radical scavenging activity of 89% by using 10mg of α-
Fe2O3/C nanocomposites. This can be explained by the electron
transfer from the nanocomposite system toward the free radical
located at the nitrogen atom in DPPH (Bhattacharya et al., 2014).
A matter of great concern for the use of nanoparticles
in biomedical field is considered the incomplete toxicological
profile of these nanomaterials, the toxicity data being somehow
controversial. A considerable number of studies were conducted
in order to verify the toxicity induced by the nanoparticles, both
in vitro and in vivo, but also in the other domains that use
nanotechnology/nanoparticles (agriculture, food sector; Balmuri
et al., 2016; Bostan et al., 2016; Neagu et al., 2016; Piperigkou
et al., 2016; Valdiglesias et al., 2016).
One of the objectives suggested in this study consisted in the
in vitro and in vivo toxicological evaluation of the biocompatible
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colloidal suspensions obtained in order to establish their safety
profile.
Taking into consideration the data that were obtained in the
section of physico-chemical characterization of the novel OA
double-layered iron oxide nanoparticles colloidal suspensions,
it was tested the effect of these suspensions in vitro on human
keratinocytes (HaCat cell line) viability. The test was performed
using Alamar blue assay. This assay relies on the capacity of
the metabolically active cells (living cells) to reduce resazurin,
the active compound from Alamar blue solution in order to
quantitatively measure the number of viable normal or cancer
cells after stimulation with test compounds (Riss et al., 2016).
Our results presented in Table 3 indicated, in the case of all
three colloidal suspensions (magnetite and maghemite oleic acid
double coated nanoparticles), a lack of toxicity induced by the
iron oxide nanoparticles colloidal suspensions after an exposure
of 24 h at the concentrations used (5, 10, and 25 µg·mL−1).
Similar results were obtained by Naseroleslami et al.
when tested different concentrations (in the range of 25–
800 µg·mL−1) of PEGylated superparamagnetic iron oxide
nanoparticles obtained by co-precipitation method on human-
derived amniotic membrane stem cells, the cell viability at
the lowest concentration (25 µg·mL−1) being 99.96 ± 0.05%
independent of exposure time (24, 48, and 72 h; Naseroleslami
et al., 2016). In a recent study developed by Joris and co-
workers, concerning the safety profile of iron oxide nanoparticles
in neural cells of different origin (human and mouse) and type
(stem cells, progenitor cell line and cancer cell line), it was
shown that iron oxide nanoparticles coated with an amphiphilic
polymer—poly(isobutylene-alt-maleic anhydride)-graft-dodecyl
(PMA) induced the lowest loss of cell viability as compared to
gold and silver nanoparticles. The highest susceptibility to acute
toxicity was observed in the case of human neural stem cells
followed by the mouse stem cells, whereas the least susceptibility
was recorded for cancer cells (Joris et al., 2016). Shete et al.
tested both uncoated and coatedmagnetite nanoparticles on L929
cell line (mouse fibroblasts) and it was observed a very low
cytotoxicity even after a period of 48 h stimulation with different
concentrations (0.1, 0.5, 1.0, 1.5, and 2.0 mg·mL−1; Shete et al.,
2015).
Pongrac et al. demonstrated that poly(L-lysine)-coated
maghemite nanoparticles after a stimulation of 48 h led to a cell
viability and proliferation around 80% at a concentration of 0.2
mg·mL−1 while a concentration similar (0.03 mg·mL−1) with the
highest concentration used in the present study (25 µg·mL−1)
was responsible for around 5% dead neural stem cells—NSC
(Pongrac et al., 2016), results that indicated a reduced degree of
toxicity induced by the iron nanoparticles.
There were also published data that affirmed the toxicity
induced by the iron oxide nanoparticles, the noxious effects being
attributed to the difference in particles size and shape, the dose
used for stimulation, and the cell type (reviewed in Valdiglesias
et al., 2016).
Another parameter tested in order to verify the in vitro effects
of the colloidal suspensions of magnetite and maghemite was
their impact on cells migration and proliferation. According to
our results (Figures 7, 8, 9), the suspensions had no effect on
HaCat cells migration at all the concentrations tested, nor after
3 h, neither after 24 h stimulation. Our data are in agreement
with the data presented by Muhammad et al. who showed
that stimulation with SPIO (superparamagnetic iron oxide)
nanoparticles of adipose-derived mouse stem cells and bone
marrow-derivedmouse stem cells did not impaired cell migration
(Muhammad et al., 2015).
The in vitro results that were obtained could be considered
a toxicological profile for the coating agent, in this case oleic
acid, since the iron oxide nanoparticles were not degraded in the
timeframe of the cytotoxicity assay—24 h.
Since the colloidal suspensions that were obtained in the
present study, represent an element of originality (no biological
studies were performed to the best of our knowledge on iron
oxide nanoparticles obtained by solution combustion synthesis
and coated with a double layer of oleic acid), to test their effects
in vivo became mandatorily.
In this study it was conducted a test of dermal acute toxicity
of the colloidal suspensions on female and male SKH-1 hairless
mice, toxicity that was verified after topical applications of the
suspensions. It was decided to perform this kind of toxicity test
based on the fact that the preliminary data obtained will represent
the fundamental basis for further in vivo studies regarding the
formulation of topical forms using iron oxide nanoparticles as
carriers for agents effective in different skin pathologies. Our data
showed that topical applications of S1, S2, and S3 suspensions had
no effect on mice body weight or on behavioral patterns.
In order to evaluate the effects induced by these colloidal
suspensions at skin level, there were measured and analyzed
several physiological skin parameters, including: skin hydration,
melanin content and erythema. The method applied was
a non-invasive assay, using the equipment from Courage-
Khazaka Electronics GmbH: Corneometer R©CM 825 and Skin
Colorimeter CL 400.
Topical application of S1 colloidal suspension in PBS led to a
decrease of skin hydration in the females group, but the initial
values of the parameter were achieved during the first 24 h post-
application (red line, Figure 10, left graph). These modifications
were not detected in the male mice group that suffered the same
protocol (red line, Figure 10, right graph). The S2 and S3 aqueous
suspensions induced an increase of skin hydration in both female
and male mice groups, hydration that was maintained during the
first 24 h (blue and yellow lines, Figure 8).
The differences between female and male mice concerning
the skin hydration recorded in the present experiment can be
explained by the sex disparities in skin structure: the males
present a lower pH value, a higher sebum content and skin
hydration values, and also a higher susceptibility to develop skin
pathologies, including cancer (Boelsma et al., 2003; Dehelean
et al., 2016).
The tristimulus colorimetry method was applied in order
to verify the changes of skin color associated to the topical
application of test suspensions. This type of method is commonly
used in dermato-cosmetic research, the parameters investigated,
melanin content and erythema being indicators of skin barrier
integrity and sensitivity after contact with different substances,
drugs or vehicles (Matias et al., 2015). This technique offers
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quantitative measurements of skin color expressed with the help
of a 3-digit output L∗, a∗ and b∗—arbitrary values, system that
is recognized by the International Commission of Illumination
(Commission Internationale de L’Eclairage—CIE; Alaluf et al.,
2002; Tzung et al., 2009). L∗ is known as lightness, brightness,
or level of darkness and can take values in the interval 0 and
100, the value 0—is black and 100 is white and is associated with
the melanin content from the external skin layers. a∗ can reach
negative or positive values between −60 and + 60, from green
to red, this marker being known as redness and is considered an
indicator for the presence of the erythema (the higher the values
is, the erythema is more intense). b∗—yellowness, the coordinate
that is related to melanin content from the skin, can be expressed
as negative or positive values from −60 (blue) to +60 (yellow;
Alaluf et al., 2002; Tzung et al., 2009; Yang et al., 2016).
There was described an inverse correlation between the L∗
and a∗ and b∗ values. The darkest type of skin presents a low
L∗ value and high values for a∗ and b∗ (Alaluf et al., 2002).
Our results indicated that in the group 1 of female mice was
observed a pigmentation after the first application of S1, whereas
the erythema signs were detected only after the second and third
application. Both pigmentation and erythema faded until the end
of 24 h. These data showed that application of S1 suspension on
female mice skin led to some changes of skin parameter, but the
change was not significant in terms of disturbing the integrity of
skin barrier function.
In the case of the second group of female mice—exposed to
S2 suspension it was detected a pigmentation that lasted for 24 h
while the erythema signs were recorded after the first application,
but after 6 h the erythema values were decreased. These dates
could be explained by the fact that S2 suspension was better
absorbed in the skin being an aqueous solution, what led to a
pigmentation for 24 h. The S3 suspension had no impact in the
group of female mice neither on the parameter related to melanin
content (L∗ and b∗), nor on the a∗—the coordinate related to
erythema.
The results recorded in the groups of male mice were
as follows: S1—application was associated with a temporary
pigmentation after the applications of the suspension (<6 h),
but no sign of erythema was recorded; S2—application led to an
increase of melanin content value that was maintained constant
in the 24 h and it was observed a slight erythema after the
application (only for 6 h) and S3—application had no impact on
melanin content, but there were recorded erythema signs after
the topical applications.
The changes observed in the skin parameters values showed
a slight disturbance associated to the topical applications of the
iron oxide nanoparticles, but these changes were temporary and
should not be interpreted as signs of toxicity.
On account of our group expertise in the field of skin
pathologies (Dehelean et al., 2013, 2016; Gheorgheosu et al.,
2013; Soica et al., 2014; Danciu et al., 2015), the present study
could be seen as a first step in the synthesis and characterization
of the magnetic iron nanoparticles double coated with oleic
acid as future carrier platforms for transdermal drug delivery in
skin malignancies (melanoma and non-melanoma skin cancers,
auto-immune diseases—epidermolysis bullosa acquisita). In this
regard was evaluated the toxicological profile of the colloidal
suspensions on human keratinocytes cell line and by applying the
dermal acute test to SKH-1 hairless mice.
The transdermal drug delivery offers several advantages as
compared to the other routes of administration (oral and
intravenous): a controlled release of the drug, avoidance of the
first hepatic metabolism and a higher patient compliance by
reducing the pain associated to i.v. administration. Oleic acid is
a FDA recognized agent for increasing skin permeation and it
is frequently applied in different commercial formulations. The
mechanism of action of oleic acid consists in: interaction with the
lipid content of the stratum corneum what leads to the changes in
the lipid bilayer, characterized by the apparition of some pools
responsible for the defects that appear in the permeability and it
is facilitated the entry of different molecules into the profound
skin layers (Shah et al., 2012).
All these data support the idea of oleic acid double coated
iron oxide nanoparticles as promising carrier platforms for drug
delivery in skin disorders.
CONCLUSIONS
In the current study were obtained biocompatible colloidal
suspensions based on iron oxide nanoparticles prepared by the
means of solution combustion synthesis and coated with a double
layer of oleic acid. TEM and DLS analyses confirmed their
nanosize features (an average particle diameter around 7–22
nm) what makes them suitable for biomedical applications, in
addition to their high stability and solubility in aqueous solutions.
Magnetite solubilized in distilled water (sample 2) exhibited an
antioxidant activity at the concentrations tested. The in vitro
evaluations of the colloidal suspensions tested indicated a lack of
toxicity on human keratinocytes cell viability, proliferation, and
migration. The in vivo acute dermal toxicity test revealed some
changes in the values of physiological skin parameters, but not
significant as to interfere with the skin barrier function. These
data offer valuable information for future studies regarding the
use of iron oxide nanoparticles as carrier platforms for drug
delivery in skin pathology.
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